A turnkey solution for forensic identification from Tecan
12 November 2013 | By kdm communications
Genia Geo has chosen Tecan’s HID EVOlution™ system as part of its comprehensive forensic identification services for governments around the world...
List view / Grid view
News
Tiësto teams up with Music Saves Lives® and Abbott to encourage young people to donate blood
With advances in medical treatments and an aging population, the demand for donated blood continues, as fewer people are becoming lifelong donors. 1In an effort to raise awareness about blood donation and encourage young adults to become repeat blood donors, Music Saves Lives® and Abbott are announcing a special opportunity…
Simeprevir administered once daily demonstrates sustained virologic response in genotype 1 chronic hepatitis C patients
11 November 2013 | By Janssen Therapeutics EMEA
HCV is a major problem in the EMEA region, where an estimated 15 million people are living with the disease...
Novartis announces divestiture of its blood transfusion diagnostics unit to Grifols
11 November 2013 | By Novartis
Spain-based Grifols to acquire Novartis blood transfusion diagnostics unit for USD 1.675 billion...
Micardis crosses 50 million patient-years of experience on 15th anniversary
11 November 2013 | By Boehringer Ingelheim
Boehringer Ingelheim announces clinical experience with its angiotensin II receptor blocker (ARB) has reached 50 million patient-years of real world experience...
AstraZeneca to invest £120 million in new manufacturing facility to produce Zoladex in Macclesfield
11 November 2013 | By AstraZeneca
Zoladex has been manufactured at AstraZeneca’s Macclesfield plant for over 25 years, supplying the medicine to more than one hundred markets around the world...
Merck’s investigational grass sublingual allergy immunotherapy tablet significantly reduced allergy symptoms and need for symptom-relief medication in adults and children
9 November 2013 | By Merck
“Patients in this study who took the investigational Timothy grass sublingual allergy immunotherapy tablet showed a significant improvement in common allergy symptoms..."
Pfizer announces top-line results of phase 3B/4 study of RAPAMUNE® (sirolimus) in renal transplant recipients
8 November 2013 | By Pfizer
The primary endpoint of the study was not achieved as there was not a statistically significant difference in renal function improvement...
Amgen Foundation commits $2.5 Million in new grants to engage 50,000 students each year in the thrill of scientific inquiry
7 November 2013 | By Amgen
Innovative program - Amgen Biotech Experience - brings real-world biotechnology lab experience to students...
Similac® partners with National Association of Hispanic Nurses® to launch StrongMoms® Español
7 November 2013 | By Abbott
Similac is trying to meet that resource need with the launch of StrongMoms Español, a free program that provides Hispanic moms relevant, Spanish-language resources...
Quotient Clinical at AAPS 2013
6 November 2013 | By kdm communications limited
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – will be showcasing the benefits of its unique, integrated approach to formulation development...
GSK announces data to support Cervarix® two-dose schedule for the prevention of cervical cancer in 9-14 year old girls
4 November 2013 | By GlaxoSmithKline
The results showed that the two-dose schedule in girls aged 9 to 14 years old induced immune responses...
Cancer Research Technology and Nuevolution sign multi-target deal to seek potential cancer drugs
4 November 2013 | By B3C Group GmbH
The collaboration aims to identify drug leads that block the activity of a number of challenging cancer therapeutic targets....
Roche and Polyphor join efforts to combat multi-drug-resistant bacterial infections
4 November 2013 | By Roche
Roche will make an upfront payment of CHF 35 million to Polyphor as well as payments upon reaching certain development...
Johnson & Johnson and its Subsidiaries conclude previously disclosed settlement agreements with U.S. Department of Justice and 45 States
4 November 2013 | By Johnson & Johnson
The resolution includes total settlement amounts of approximately $2 billion to the federal government...
